Managing patients with hematological malignancies during COVID-19 pandemic
Kamal Kant Sahu, Jan Černý
Abstract
The outbreak of the coronavirus disease 2019 (COVID‐19) has posed an unprecedented challenge to the health care communities across the globe. As of June 17th, 2020, a total of 8,339,829 confirmed COVID-19 cases with 448,420 deaths have been reported [2]. Different parts of the world are seeing different levels of COVID-19 activity with regards to the infection rate, susceptible population, and mortality rate. The COVID-19 pandemic is a rapidly evolving emergency and is a subject of regular debate and advanced research. Patients with hematological disorders and solid malignancies have special needs and oncologists are facing a compound challenge.
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)Outbreak2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusIntensive care medicineDiseaseVirologyInfectious disease (medical specialty)Internal medicineCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction